Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors

Published:2019-12-02 Issue:12 Volume:15 Page:993-1004
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Fazio Nicola¹,Cella Chiara A.¹,Del Re Marzia²,Laffi Alice¹,Rubino Manila¹,Zagami Paola¹,Spada Francesca¹

Affiliation:

1. Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy

2. Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2019.1700951

Reference87 articles.

1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

4. Molecular basis of angiogenesis and cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges;Cancers;2024-02-15

2. Non-Functioning Pancreatic Neuroendocrine Tumors;Neuroendocrine Tumours;2024

3. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management;Baylor University Medical Center Proceedings;2023-12-20

4. Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms;Endocrine-Related Cancer;2023-09-15

5. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options;World Journal of Gastroenterology;2022-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3